Skip to main content

Press releases | August 18, 2020

Fried Frank acted as counsel to BofA Securities, Inc. as financial advisor to Principia Biopharma Inc. (Principia) in its US$3.4 billion sale to Sanofi S.A. (Sanofi). Principia is a San Francisco-based biotech company. Sanofi is a French multinational pharmaceutical company. The transaction is the second largest pharmaceutical acquisition of 2020.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.